In Regard to Habl et al

Affiliations

¹ Provision Center for Proton Therapy, Knoxville, Tennessee.
² Northwestern Medicine Chicago Proton Center, Chicago, Illinois.
³ Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri.
⁴ Procure Proton Center, Somerset, New Jersey.
⁵ Mayo Clinic, Rochester, Minnesota.

Comment

Marcio Fagundes et al. Int J Radiat Oncol Biol Phys. 2016.

. 2016 Sep 1;96(1):241-2.

doi: 10.1016/j.ijrobp.2016.04.006.

¹ Provision Center for Proton Therapy, Knoxville, Tennessee.
² Northwestern Medicine Chicago Proton Center, Chicago, Illinois.
³ Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri.
⁴ Procure Proton Center, Somerset, New Jersey.
⁵ Mayo Clinic, Rochester, Minnesota.

No abstract available

Comment on

Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
Habl G, Uhl M, Katayama S, Kessel KA, Hatiboglu G, Hadaschik B, Edler L, Tichy D, Ellerbrock M, Haberer T, Wolf MB, Schlemmer HP, Debus J, Herfarth K. Habl G, et al. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):435-443. doi: 10.1016/j.ijrobp.2016.02.025. Epub 2016 Feb 12. Int J Radiat Oncol Biol Phys. 2016. PMID: 27084659 Clinical Trial.